The overexpression of DDX5 in Huh7 xenografts not only suppressed tumor growth following sorafenib treatment [7] but also repressed the protein level of p62/SQSTM1, a positive upstream effector of NRF2 stability (Fig. 6). Here, SQSTM1 is linked to neoplasm.